What to Eat on GLP-1 Medications (Ozempic, Wegovy, Zepbound): A Nutrition Guide

GLP-1 receptor agonists (semaglutide in Ozempic and Wegovy, tirzepatide in Mounjaro and Zepbound) work by mimicking a gut hormone that is released naturally after eating. That hormone does three things relevant to food: it slows gastric emptying so food sits in the stomach longer, it signals fullness to the brain earlier and more strongly, and it reduces the reward and craving signals that drive snacking and portion size. The practical result is a dramatic, mechanical drop in appetite — many people describe going from finishing a full plate to feeling done after a few bites, sometimes within the first two or three doses.

This is the intended effect and it is largely why the drugs work. But appetite suppression does not selectively target excess calories — it reduces total intake indiscriminately, protein and micronutrients included. A person eating 1,100–1,400 calories a day because they genuinely cannot manage more has very little margin for error: if a meaningful share of those calories isn't protein, and isn't nutrient-dense, deficits show up fast. The rest of this guide is essentially about protecting that narrow margin.

If you take away one thing from this guide, make it this: prioritize protein at every eating occasion, before anything else on the plate. In the STEP 1 body-composition substudy, lean mass accounted for roughly 40% of total weight lost; in SURMOUNT-1's DXA substudy, tirzepatide users lost about 10.9% of lean mass alongside a 33.9% drop in fat mass over 72 weeks — around a quarter of total weight lost came from lean tissue. Some of that lean-mass loss is an expected consequence of rapid weight loss itself, not unique to these drugs, and losing some muscle alongside large amounts of fat is not automatically alarming. But a 2024 review of mitigation strategies for GLP-1-associated lean mass loss identified adequate protein intake and resistance exercise as the two levers patients and clinicians can actually influence.

Meta-analytic evidence from calorie-restricted diets more broadly backs this: higher-protein, energy-restricted diets preserve significantly more lean mass than standard-protein diets at the same calorie deficit. A practical target discussed in clinical nutrition guidance for this population is roughly 1.2–1.6 grams of protein per kilogram of goal body weight per day — meaningfully higher than general population recommendations, and genuinely difficult to hit on a suppressed appetite unless protein is deliberately front-loaded.

Severely reduced food volume is the same underlying mechanism that causes micronutrient shortfalls after bariatric surgery, even though GLP-1 medications don't alter absorption the way surgery does. Clinical nutrition guidance for bariatric patients — a useful reference point given the overlapping calorie restriction — flags vitamin B12, iron, vitamin D, folate, and thiamine (vitamin B1) as the nutrients most likely to run low when intake drops sharply for an extended period, particularly if meat, dairy, and fortified grains make up a smaller share of a shrunken diet.

B12 deserves particular attention: absorption depends partly on stomach acid and intrinsic factor, and it's plausible for intake of B12-rich foods (meat, fish, eggs, dairy) to drop simply because they're heavier, harder-to-finish foods when nausea or early fullness is present. Thiamine is worth flagging separately because deficiency can develop over just weeks of very low intake or persistent vomiting, and symptoms (fatigue, confusion, unsteady gait) are easy to misattribute to "just being on the medication." If you're eating well below your usual intake for more than a few weeks, ask your prescribing clinician whether baseline bloodwork or a general multivitamin makes sense for your situation — this is a conversation for your care team, not a self-directed supplement regimen.

Gastrointestinal side effects are common and expected, not a sign something is wrong: a multidisciplinary expert consensus on managing GI adverse events with GLP-1 receptor agonists notes that nausea, vomiting, diarrhea, and constipation collectively affect a large share of patients, especially during dose increases, with nausea alone reported by roughly 15–50% of users depending on the agent and dose. The same consensus statement centers dietary modification as the first-line response, ahead of medication changes.

For nausea: eat smaller portions more frequently rather than three large meals; stop eating at the first sign of fullness rather than pushing to "finish the plate"; avoid high-fat and fried foods, which slow gastric emptying further and worsen the sensation of food sitting heavy; keep ginger tea, dry crackers, or plain toast on hand for flare-ups; and eat slowly, since the drugs are actively delaying the fullness signal from reaching your brain. For constipation, driven partly by slowed gut transit and partly by simply eating less fiber and fluid overall: prioritize fluid intake (aim for steady sipping through the day rather than large volumes at once, which can worsen fullness), include a fiber source at most meals (chia, oats, berries, leafy greens), and consider that a magnesium citrate supplement or stool softener may be worth discussing with your doctor if dietary changes aren't enough. For dumping-syndrome-like symptoms (lightheadedness, cramping, diarrhea shortly after eating, more common with tirzepatide and higher doses) — avoid large boluses of simple sugar or juice on an empty stomach, and pair any carbohydrate with protein or fat to slow absorption.

Standard "three square meals" advice breaks down fast on these medications. If you're realistically eating 2–4 tablespoons of food before feeling done, the structure that works better is small, nutrient-dense, protein-anchored mini-meals spaced through the day — four to six small eating occasions rather than three large ones most people find easier to actually complete. The goal of each mini-meal is to deliver protein first, since that's the macronutrient most likely to fall short and the one doing the most work to protect lean mass.

Practical mini-meal building blocks: a hard-boiled egg plus a few berries; a small portion of Greek yogurt with a spoonful of nut butter; 2–3 oz of leftover chicken or salmon; a protein shake when solid food feels unmanageable (useful as a supplement to real food, not a full replacement for it long-term); cottage cheese with sliced fruit; or a small omelet. Because volume is so limited, avoid spending it on foods with little nutritional payoff — a few bites of chips or bread deliver almost no protein or micronutrients and displace something that would. This is also why quality trumps quantity so completely on these medications: every bite has to earn its place.

FOODS THAT WORK WELL: lean proteins that are easy to digest in small portions — eggs, Greek yogurt, cottage cheese, fish, skinless poultry, tofu, and protein shakes/powders when appetite is very low; broth-based soups with added protein (shredded chicken, lentils); soft-cooked vegetables, which are gentler on a slowed-down gut than raw, fibrous ones during flare-ups; whole fruit in small portions for fiber plus micronutrients; healthy fats in small amounts (avocado, olive oil, nut butter) for calorie density without needing large volume.

FOODS TO LIMIT: fried and greasy foods, which are the most consistent trigger for nausea and reflux due to slowed gastric emptying; very large portions of anything, since overshooting your new capacity is what causes the vomiting and discomfort people report most; carbonated drinks, which can worsen bloating and early fullness; alcohol, which irritates an already slower gut and adds calories without nutritional value at a time when every calorie needs to count; and low-protein "empty volume" foods like chips, crackers, and sugary snacks that fill limited stomach space without contributing to the protein target. None of these are permanently forbidden — the point is that capacity is scarce, so what you spend it on matters more than it used to.

This is illustrative, not prescriptive — individual calorie and protein needs vary by body size, activity level, and stage of treatment, and should be discussed with a registered dietitian where possible. Breakfast: one scrambled egg with a small spoon of cottage cheese, or a half-portion protein shake if solid food feels difficult early in the day. Mid-morning: a few walnuts and a small handful of berries. Lunch: 2–3 oz of grilled chicken or salmon with a small serving of soft-cooked vegetables — stop as soon as fullness hits, even mid-plate. Afternoon: plain Greek yogurt with a drizzle of honey. Dinner: a small portion of fish or tofu with a few bites of a starchy vegetable like sweet potato. Evening (if tolerated): a small glass of milk or a protein-fortified snack.

The throughline across the day is protein at every single occasion, however small, plus consistent fluid intake between (not during) meals to avoid filling limited stomach capacity with liquid. Total daily protein in an example like this lands somewhere in the 70–100g range for many adults, which is realistic even on a significantly reduced calorie intake precisely because it's distributed across many small opportunities rather than concentrated in one meal that never gets finished.

GLP-1 medications are typically framed by prescribers as long-term or indefinite treatments for chronic weight management, similar to how blood pressure medication is treated — not a short course with a defined end date. That framing matters nutritionally: the eating patterns you build now (protein-first meals, consistent small portions, minimizing empty-calorie foods) are worth establishing as durable habits, not temporary workarounds, because appetite suppression can fade if a dose is reduced, paused, or stopped, and old eating patterns tend to resurface with it.

What the evidence says about stopping: weight regain after discontinuation has been observed in trial extension data, and much of that regain trends toward fat rather than lean mass — but this depends heavily on whether the protein-forward, resistance-exercise habits built during treatment are maintained afterward. This is precisely why treating this guide's recommendations as "things I do while on the drug" rather than "things I do because they build muscle-protective habits I'll keep either way" matters. If you and your clinician are considering dose changes or discontinuation for any reason, loop in a registered dietitian beforehand if you can — the transition period, when appetite is normalizing but old habits haven't yet returned, is a high-leverage window for locking in the food patterns that will serve you regardless of what happens with the medication.